Michael Severino

Dr. Michael E.
Severino, MD, is an Independent Director at Viatris, Inc., a Chief Executive Officer & Director at Tessera Therapeutics, Inc. and an Independent Director at Avantor, Inc. He is on the Board of Directors at Viatris, Inc., Montai Therapeutics, Inc., Tessera Therapeutics, Inc., Avantor, Inc., Biotechnology Innovation Organization and The Field Museum of Natural History.
Dr. Severino was previously employed as a President & Vice Chairman-Management Board by AbbVie, Inc., a Chief Medical Officer & SVP-Global Development by Amgen, Inc., a Senior Vice President by Amgen Ventures LLC, and a Senior Director by Merck Research Laboratories Massachusetts LLC.
He received his undergraduate degree from the University of Maryland and a doctorate degree from The Johns Hopkins University.